Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Rossi M
Blood. 138(21):2093-2105. doi: 10.1182/blood.2021011320
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.
GenoMed4All consortium
Lancet Haematol. 2022 Nov 24;10(2):e117-e128. doi: 10.1016/S2352-3026(22)00323-4
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Sauta E
J Clin Oncol. 2023 Mar 17;41(15):2827-2842. doi: 10.1200/JCO.22.01784
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.
Siddiqui I
J Immunother Cancer. 2016 Apr 19;4:21. doi: 10.1186/s40425-016-0125-1
Heme-oxygenase-1 Production by Intestinal CX3CR1(+) Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.
Marelli G
Cancer Res. 2017 Jun 15;77(16):4472-4485. doi: 10.1158/0008-5472.CAN-16-2501
Targeting tumor associated macrophages: The new challenge for nanomedicine.
Andón FT
Semin Immunol. 2017 Sep 21;34:103-113. doi: 10.1016/j.smim.2017.09.004
Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.
Siddiqui I
Oncoimmunology. 2017 Nov 1;7(2):e1388485. doi: 10.1080/2162402X.2017.1388485
Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors.
Dacoba TG
Front Immunol. 2020 Jul 7;11:1412. doi: 10.3389/fimmu.2020.01412
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective.
Allavena P
Clin Cancer Res. 2021 Feb 2;27(12):3291-3297. doi: 10.1158/1078-0432.CCR-20-1679
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice.
Digifico E
Cancers (Basel). 2020 Aug 1;12(8)doi: 10.3390/cancers12082136